scd411
Showing 1 - 1 of 1
Wet Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration Trial in Worldwide (SCD411, Aflibercept)
Active, not recruiting
- Wet Age-related Macular Degeneration
- Neovascular Age-related Macular Degeneration
- SCD411
- Aflibercept
-
Beverly Hills, California
- +139 more
May 11, 2022